Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-15,476
Closed -$2.54M 85
2017
Q1
$2.54M Hold
15,476
0.18% 36
2016
Q4
$2.26M Hold
15,476
0.16% 40
2016
Q3
$2.58M Hold
15,476
0.16% 41
2016
Q2
$2.35M Hold
15,476
0.17% 39
2016
Q1
$2.32M Hold
15,476
0.15% 40
2015
Q4
$2.51M Hold
15,476
0.18% 36
2015
Q3
$2.14M Hold
15,476
0.16% 38
2015
Q2
$2.38M Hold
15,476
0.17% 39
2015
Q1
$2.47M Hold
15,476
0.18% 37
2014
Q4
$2.46M Hold
15,476
0.18% 37
2014
Q3
$2.17M Sell
15,476
-9,433
-38% -$1.23M 0.15% 41
2014
Q2
$2.95M Hold
24,909
0.2% 42
2014
Q1
$3.07M Hold
24,909
0.2% 43
2013
Q4
$2.84M Hold
24,909
0.18% 45
2013
Q3
$2.79M Sell
24,909
-14,828
-37% -$1.61M 0.17% 43
2013
Q2
$3.92M Buy
+39,737
New +$4.12M 0.23% 37

Other funds holding AMGN

Jasper Ridge Partners's AMGN Position: Q2 2017 in Review

Jasper Ridge Partners sold out of Amgen (AMGN) in Q2 2017, closing a stake of 15,476 shares — an estimated $2.54M sold.

Jasper Ridge Partners first reported a position in AMGN in Q2 2013 and held it in 16 quarters. The position peaked at $3.92M in Q2 2013. 1,596 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Jasper Ridge Partners reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
  • Jasper Ridge Partners sold 15,476 Amgen shares in Q2 2017, an estimated $2.54M.
  • Jasper Ridge Partners first reported a position in Amgen in Q2 2013 and held it in 16 quarters.
  • Jasper Ridge Partners's Amgen position peaked at $3.92M in Q2 2013.
  • 1,596 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Jasper Ridge Partners's 13F filing for Q2 2017, filed 10 Aug 2017.